Teleflex Incorporated, a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an expansion to the Indications for Use of the QuikClot Control+? Hemostatic Device

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its enterprise imaging solution as a cloud service, Sectra One Cloud, to a US cancer center under a new agreement.

MemorialCare Long Beach Medical Center has made history by becoming the first hospital globally to successfully perform a robotic hip revision surgery utilizing Stryker's groundbreaking Mako Total Hip with 5.0 Advanced Primary

FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study.

IceCure Medical Ltd.?developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced its participation at the Society of Breast Imaging (SBI)

Clarius Mobile Health, a pioneer in AI-powered handheld ultrasound, is introducing Clarius Prostate AI, an FDA cleared semi-automatic tool that quickly and accurately calculates prostate volume during an ultrasound exam. Measuring prostate volume

GE HealthCare, a global leader in breast health technologies, is set to showcase its latest innovations at the 2025 Society of Breast Imaging Symposium. The event will be held in Colorado Springs, United States, from 24 to 27 April 2025.

HeartBeam, Inc.?a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a strategic collaboration with AccurKardia, an innovator in ECG-based diagnostics technology

Baebies has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Anti-Factor Xa test on the FINDER? platform ?the first point-of-care heparin monitoring assay. Designed for patients receiving unfractionated

CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced it has received its second Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)